"Pyridostigmine Bromide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
| Descriptor ID |
D011729
|
| MeSH Number(s) |
D03.383.725.762.740
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pyridostigmine Bromide".
Below are MeSH descriptors whose meaning is more specific than "Pyridostigmine Bromide".
This graph shows the total number of publications written about "Pyridostigmine Bromide" by people in this website by year, and whether "Pyridostigmine Bromide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pyridostigmine Bromide" by people in Profiles.
-
Mawson AR, Croft AM. Gulf War Illness: Unifying Hypothesis for a Continuing Health Problem. Int J Environ Res Public Health. 2019 01 03; 16(1).
-
Berr?os VO, Boukli NM, Rodriguez JW, Negraes PD, Schwindt TT, Trujillo CA, Oliveira SL, Cubano LA, Ferchmin PA, Eterovic VA, Ulrich H, Martins AH. Paraoxon and Pyridostigmine Interfere with Neural Stem Cell Differentiation. Neurochem Res. 2015 Oct; 40(10):2091-101.
-
Li Y, Lein PJ, Liu C, Bruun DA, Giulivi C, Ford GD, Tewolde T, Ross-Inta C, Ford BD. Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury. Toxicol Appl Pharmacol. 2012 Jul 15; 262(2):194-204.